Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme. Its products includes prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines and other medical produc... ts. The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis. On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi  operates in over 100 countries throughout the world.

#SimilarOrganizations #People #Financial #Event #Website #More


Social Links:

Biotechnology Health Care Life Science Manufacturing Marketing Medical Pharmaceutical Therapeutics


Paris, Ile-de-France, France


Website Url:

Total Employee:



Email Addresses:
[email protected]

Total Funding:
639.02 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Apache Nginx Amazon

45.39 B
Total Assets:
126.72 B
Total Cash:
12.74 B

Similar Organizations


adinotec AG

The adinotec AG with registered office in Griesheim (Germany) is active in the development, production, and marketing of innovative


Allergan France

Allergan France concentrates on manufacturing and marketing of originator pharmaceuticals.


Aseptic Technologies

Aseptic Technologies develops, manufactures and markets equipment.


Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.



Axcella is a biotechnology company providing therapeutics development solutions.



BioSystems researches, develops, produces and markets effective and reliable analytical systems for laboratories around the world.



CRYOFIT is involved in the research, development, and production of biological glue used during surgical intervention and medical processes.



Explera is engages in importing, manufacturing, and marketing products in the molecular biology field for research laboratories.


GABA International

GABA International is engaged in the research, development, manufacture, and marketing of oral care products.


Intana Bioscience GmbH

Lleading experts in customized assay development, screening and target/hit validation using fluorescence cross-correlation spectroscopy


JA Saúde Animal

J.A Saúde Animal specializes in research, development, manufacturing, and commercialization of products for animal health.


Jiangyuyi Chuang

Jiangyuyi Chuang engages in the research and development, manufacturing, and sales of medical testing equipment and smart wearable devices.


Kellsa Diagnostics

Kellsa Diagnostics are research, development, production and marketing of healthcare products and equipment, in particular diagnostics.



Phaseform develops next-generation adaptive optics systems based on innovative hardware and software

Current Advisors List


Robert Castaigne Member of the Board of Directors @ Sanofi


Rene Fourtou Member of the Board of Directors @ Sanofi


Uwe Bicker Member of the Board of Directors @ Sanofi


Christian Mulliez Member of the Board of Directors @ Sanofi


Carole Piwnica Member of the Board of Directors @ Sanofi


Patrick Kron Member of the Board of Directors @ Sanofi


Klaus Pohle Member of the Board of Directors @ Sanofi


Carole Piwnica Member of the Board of Directors @ Sanofi

Current Employees Featured


Patricia Roselle
Patricia Roselle Global Head, Patient Network Management @ Sanofi
Global Head, Patient Network Management


Franqui Jimenez
Franqui Jimenez Business Partner Rare Disease Cluster, Global MSAT @ Sanofi
Business Partner Rare Disease Cluster, Global MSAT


Jean-Baptiste Chasseloup de Chatillon
Jean-Baptiste Chasseloup de Chatillon Executive Vice President & CFO @ Sanofi
Executive Vice President & CFO


Jean-Pierre Adiceom
Jean-Pierre Adiceom Responsable Financier @ Sanofi
Responsable Financier


Lucia Cardenas Melgarejo
Lucia Cardenas Melgarejo Global Digital Agency Relationship & Digital Marketing // Consumer Healthcare @ Sanofi
Global Digital Agency Relationship & Digital Marketing // Consumer Healthcare


Jiuyi Lu
Jiuyi Lu Associate Director in Cell Culture Development @ Sanofi
Associate Director in Cell Culture Development


Olivier Brandicourt
Olivier Brandicourt Chief Executive Officer @ Sanofi
Chief Executive Officer


William Napoli
William Napoli Principal Engineer @ Sanofi
Principal Engineer


Yan He
Yan He Head of Early Formulation Development, U.S. @ Sanofi
Head of Early Formulation Development, U.S.


Bill Sibold
Bill Sibold Executive Vice President @ Sanofi
Executive Vice President



Jean-François Dehecq


Jean-René Sautier

Stock Details

Company's stock symbol is SNY. Lastest price : 50.88$. Total volume :744.17k Click reload if you want to check the lastest price on market!!!
Exchange NasdaqGS. Currency in USD. Market state REGULAR

Sanofi (SNY)
Last Price
0.43$ (0.85%)

Previous Close 50.45
Open 50.66
Day Range 50.40-50.91
Bid 50.87 x 800
Ask 50.88 x 1.2k
Volume 744.17k
Average Volume 1.73M
Market Cap 133.62B
Beta 0.40
52 Week Range 36.91-57.82
Trailing P/E 14.25
Foward P/E 5.78
Dividend (Yield %) 3.77%
Ex-Dividend Date 2023-05-30

Financial Details

According to Sanofi's financial reports the company's revenue in 2022 were 45.39B an increase( +15.38%) over the years 2021 revenue that were of 39.17B. In 2022 the company's total earnings were 8.37B while total earnings in 2021 were 6.22B( +33.33%).

Loading ...

Acquisitions List

Date Company Article Price
2021-12-20 Amunix Amunix acquired by Sanofi 1000 M USD
2021-12-01 Origimm Origimm acquired by Sanofi N/A
2021-09-08 Kadmon Kadmon acquired by Sanofi 1.9 B USD
2021-08-03 Translate Bio Translate Bio acquired by Sanofi 3.2 B USD
2021-04-09 Tidal Therapeutics Tidal Therapeutics acquired by Sanofi 160 M USD
2021-01-11 Kymab Kymab acquired by Sanofi 1.1 B USD
2020-11-02 Kiadis Pharma Kiadis Pharma acquired by Sanofi 308 M EUR
2020-08-17 Principia Biopharma Principia Biopharma acquired by Sanofi 3.68 B USD
2019-12-09 Synthorx Synthorx acquired by Sanofi 2.5 B USD
2018-01-29 Ablynx Ablynx acquired by Sanofi 3.9 B EUR

Investors List


Blackstone Life Sciences

Blackstone Life Sciences investment in Post-IPO Equity - Sanofi



Evotec investment in Post-IPO Equity - Sanofi

Investments List

Date Company Article Money raised
2022-08-04 Innovent Biologics Sanofi investment in Post-IPO Equity - Innovent Biologics 2.42 B HKD
2022-07-12 Areteia Therapeutics Sanofi investment in Series A - Areteia Therapeutics 350 M USD
2022-01-10 Exscientia Sanofi investment in Post-IPO Equity - Exscientia 100 M USD
2021-11-18 Owkin Sanofi investment in Corporate Round - Owkin 180 M USD
2021-11-08 Gyroscope Therapeutics Sanofi investment in Corporate Round - Gyroscope Therapeutics 60 M USD
2021-02-16 Novadiscovery Sanofi investment in Series A - Novadiscovery 2.5 M EUR
2019-10-03 Icosavax Sanofi investment in Series A - Icosavax 51 M USD
2019-09-05 Veralox Therapeutics Sanofi investment in Seed Round - Veralox Therapeutics 5.4 M USD
2019-02-05 Aetion Sanofi investment in Series B - Aetion 27 M USD
2019-01-04 BioNTech Sanofi investment in Corporate Round - BioNTech 80 M EUR

Newest Events participated

vivatech-2022_event_image Participated in Vivatech 2022 on 2022-06-15 as sponsor

masschallenge-virtual-startup-showcase_event_image Participated in MassChallenge Virtual Startup Showcase on 2021-06-16 as sponsor

masschallenge-from-idea-to-ipo_event_image Participated in MassChallenge: From Idea to IPO on 2021-02-17 as sponsor

startupbootcamp-fintech-cairo-demo-day_event_image Participated in Startupbootcamp FinTech Cairo Demo Day on 2020-09-07 as sponsor

startupbootcamp-sport-eventtech-melbourne-demo-day_event_image Participated in Startupbootcamp Sport & EventTech Melbourne Demo Day on 2020-08-20 as sponsor

startupbootcamp-commerce-amsterdam_event_image Participated in Startupbootcamp Commerce Amsterdam on 2020-06-18 as sponsor

startupbootcamp-scale-fintech-mexico-city-demo-day_event_image Participated in Startupbootcamp Scale FinTech Mexico City Demo Day on 2020-05-07 as sponsor

masschallenge-boston-2019-awards-ceremony_event_image Participated in MassChallenge Boston 2019 Awards Ceremony on 2019-10-24 as sponsor

Official Site Inspections Semrush global rank: 242.17 K Semrush visits lastest month: 290.85 K

  • Host name:
  • IP address:
  • Location: Dublin Ireland
  • Latitude: 53.3338
  • Longitude: -6.2488
  • Timezone: Europe/Dublin
  • Postal: D02

Loading ...

More informations about "Sanofi" on Search Engine

Sanofi, an innovative global healthcare company - Sanofi

Apr 27, 2023 Sanofi, an innovative global healthcare company - Sanofi Dream Big: Building a better world, one LEGO ® brick at a time READ MORE FINANCIAL RESULTS …See details»

Our Company - Sanofi

Home Our Company Lucille Pernot, Sanofi’s R&D platform, Vitry-sur-Seine, France Our Company We are an innovative global healthcare company with one purpose: to chase …See details»

Homepage - Sanofi in Canada

At Sanofi, our drive to transform the practice of medicine has taken on increased urgency since the emergence of COVID-19 across the world. READ MORE Recall of Zantac …See details»

Sanofi - Wikipedia

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and …See details»

Sanofi | Company Overview & News - Forbes

Sanofi | Company Overview & News PROFILE Sanofi Paris, France About Sanofi Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the...See details»

Sanofi announces positive data for frexalimab product to treat …

May 31, 2023 French healthcare company Sanofi announced on Wednesday positive data for its frexalimab product aimed at treating multiple sclerosis, and that the firm plans to …See details»

Sanofi: smoker's lung drug benefit was swift and sustained in trial

May 22, 2023 The benefits of Sanofi and Regeneron's anti-inflammatory drug Dupixent set in quickly during a trial to treat "smoker's lung" and lasted for the duration of the 1-year …See details»

Sanofi Applauds Supreme Court Ruling Supporting Scientific …

May 18, 2023 Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward …See details»

Government, Sanofi officials unveil $925M in vaccine funding in …

Mar 31, 2021 Toronto Government, Sanofi officials unveil $925M in vaccine funding in Toronto Sanofi, which has a North York facility, will bolster its vaccine manufacturing …See details»

Sanofi to build new facility in Canada to increase global …

Mar 31, 2014 Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward …See details»

The Government of Canada makes historic investment to …

Mar 31, 2021 Sanofi is a leading pharmaceutical manufacturer and a global leader in the development of drugs and vaccines. Sanofi has been present in Canada since 1917, …See details»

Prescription Products - Sanofi in Canada

Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are …See details»

Our science - Sanofi

Our science - Sanofi Nizar El Murr, Principal Scientist and Lab Head in immuno-oncology with his team Our Science We’re determined to find answers for patients, and to develop …See details»

Vaccines - Sanofi

Vaccines. From providing protection against disease at every stage of life to protecting humanity against emerging epidemics, vaccines help create and maintain healthy …See details»

Sanofi to enhance synergy with China’s pharma market

18 hours ago China is Sanofi’s second-largest market, behind only the United States, and revenue from China in 2022 reached about €3.12bil (RM16bil), up 6.2% year-on-year.See details»

Was This $3 Billion Deal a Wise Move for Sanofi?

4 hours ago Sanofi ( SNY 0.20%) recently opted for the former strategy to strengthen its business. In late April, the company completed its acquisition of Provention Bio for $2.9 …See details»

Sanofi Wins Supreme Court Patent Dispute With Amgen - WSJ

May 18, 2023 WASHINGTON—The Supreme Court said Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted by the patent office, handing a …See details»

Sanofi-Aventis | French company | Britannica

Sanofi originated in 1973 as a subsidiary of French petrochemical firm Elf Aquitaine (acquired by Total in 2000). Synthélabo, another pharmaceutical firm, was founded in …See details»

Investor Relations - Sanofi

Sanofi is pleased to host investors and analysts for its Vaccines Investor Event held in person on June 29th, 2023 at the Andaz hotel, 40 Liverpool Street, London EC2M 7QN, …See details»

Home - Sanofi U.S.

Apr 4, 2023 A Million Conversations. January 1, 2023. People need healthcare systems – at all levels – to better reflect society. So we must listen to marginalized communities …See details»